Published in PLoS One on September 22, 2017
Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20
[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe (1987) 7.27
Tumor stroma and regulation of cancer development. Annu Rev Pathol (2006) 6.66
Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev (2011) 5.64
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol (1999) 5.02
Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol (1996) 4.06
T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J (2003) 3.82
Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell (2006) 3.28
Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem (1997) 3.08
Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci (2006) 2.51
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem (2007) 2.44
Rho- and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/moesin proteins. J Cell Biol (1997) 2.35
Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol (2010) 2.14
Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood (2010) 2.04
Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest (2008) 2.00
Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer (2005) 1.96
Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci (2007) 1.64
Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer (2008) 1.59
Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci (1999) 1.54
The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis. Am J Pathol (2007) 1.46
Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol Carcinog (1997) 1.38
Interaction of radixin with Rho small G protein GDP/GTP exchange protein Dbl. Oncogene (1998) 1.35
CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology (2010) 1.33
Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression. Cancer Res (2011) 1.26
Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol (2008) 1.19
Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival. Arch Pathol Lab Med (2010) 1.06
Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma. Chest (2012) 1.05
Podoplanin is regulated by AP-1 and promotes platelet aggregation and cell migration in osteosarcoma. Am J Pathol (2011) 1.02
New human microvascular endothelial cell lines with specific adhesion molecules phenotypes. Endothelium (2002) 1.00
T1alpha/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells. Am J Physiol Lung Cell Mol Physiol (2008) 1.00
Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus. Clin Exp Metastasis (2012) 0.99
Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. Mol Cancer (2013) 0.98
Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene. Proc Natl Acad Sci U S A (1989) 0.98
Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. Histopathology (2011) 0.96
Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression. Lab Invest (2000) 0.95
Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface. Cell Signal (2010) 0.93
Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment. Exp Cell Res (2010) 0.93
Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. J Biol Chem (2013) 0.93
Endothelial cell tube formation assay for the in vitro study of angiogenesis. J Vis Exp (2014) 0.93
The yin, the yang, and the angiopoietin-1. J Clin Invest (2011) 0.92
Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Res Treat (2012) 0.90
Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Res (1991) 0.89
Podoplanin expression in cancer-associated fibroblasts predicts aggressive behavior in melanoma. J Cutan Pathol (2014) 0.89
Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma. Int J Cancer (2015) 0.87
[WHO classification of tumors of the breast]. Zhonghua Wai Ke Za Zhi (2014) 0.85
Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity. Biochem Biophys Res Commun (2012) 0.84
Podoplanin - a small glycoprotein with many faces. Am J Cancer Res (2016) 0.81
Podoplanin expression in cancer-associated fibroblasts correlates with VEGF-C expression in cancer cells of invasive ductal breast carcinoma. Neoplasma (2013) 0.80
Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions. Cytokine Growth Factor Rev (2016) 0.78
A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection. Cancer Lett (2017) 0.76
Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization. Oncotarget (2017) 0.76
Correlation of HIWI and HILI Expression with Cancer Stem Cell Markers in Colorectal Cancer. Anticancer Res (2015) 0.82
Expression of EMT Markers SLUG and TWIST in Breast Cancer. Anticancer Res (2015) 0.77
Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas. Anticancer Res (2015) 0.77
Impact of Physical Training on Sex Hormones and Their Receptors During N-Methyl-N-nitrosourea-induced Carcinogenesis in Rats. Anticancer Res (2017) 0.77
SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis. Cancer Genomics Proteomics (2016) 0.77
Expression of Cell Cycle-Related Proteins p16, p27, p53 and Ki-67 in HPV-positive and -negative Samples of Papillomas of the Upper Respiratory Tract. Anticancer Res (2016) 0.76
Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer. Int J Oncol (2015) 0.76
Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides. Anticancer Res (2016) 0.75
Prolactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients. Am J Cancer Res (2016) 0.75
Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study. Anticancer Res (2017) 0.75
Metallothionein-3. Adv Anat Embryol Cell Biol (2016) 0.75
SOX18 Expression in Non-melanoma Skin Cancer. Anticancer Res (2016) 0.75
Nestin-positive microvessel density is an independent prognostic factor in breast cancer. Int J Oncol (2017) 0.75
Plasminogen Activation System in Rectal Adenocarcinoma. Anticancer Res (2015) 0.75
Introduction. Adv Anat Embryol Cell Biol (2016) 0.75
Metallothioneins and Immune Function. Adv Anat Embryol Cell Biol (2016) 0.75
Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions. Anticancer Res (2017) 0.75
Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas. Anticancer Res (2017) 0.75
Expression of Metallothionein and Vascular Endothelial Growth Factor Isoforms in Breast Cancer Cells. In Vivo (2016) 0.75
Expression of metallothionein 3 in ductal breast cancer. Int J Oncol (2016) 0.75
The lack of evidence for correlation of pyruvate kinase M2 expression with tumor grade in non-small cell lung cancer. Anticancer Res (2014) 0.75
Expression of CD31 in Mycosis Fungoides. Anticancer Res (2016) 0.75
The Role of Metallothioneins in Carcinogenesis. Adv Anat Embryol Cell Biol (2016) 0.75
Metallothioneins: Structure and Functions. Adv Anat Embryol Cell Biol (2016) 0.75
Correlation Between Expression of Twist and Podoplanin in Ductal Breast Carcinoma. Anticancer Res (2017) 0.75